RBC Capital Reiterates Sector Perform on Neumora Therapeutics, Maintains $4 Price Target

BenzingaMar 4 10:04 ET · Ratings

Needham Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Cuts Target Price to $5

Moomoo NewsMar 4 08:33 ET · Ratings

Neumora Therapeutics to Present at Leerink Global Healthcare Conference

GlobeNewswireMar 4 08:30 ET

RBC Capital Downgrades Neumora Therapeutics(NMRA.US) to Hold Rating, Cuts Target Price to $4

Moomoo NewsMar 4 07:31 ET · Ratings

Express News | Needham Reiterates Buy on Neumora Therapeutics, Maintains $5 Price Target

BenzingaMar 4 07:24 ET

Neumora Therapeutics Price Target Cut to $18.00/Share From $30.00 by HC Wainwright & Co.

Dow JonesMar 4 06:53 ET · Ratings